Current Month 2011
Article Features
  3D Breast Imaging Could Revolutionize Cancer Screening
Addition of 3-D Imaging Technique to Mammography Increases Breast Cancer Detection Rate
Anti-Androgen Receptor Therapy for Triple-Negative Breast Cancer May Benefit More Than Just High-Androgen Receptor Tumors
Barriers To Obtaining Gene Expression Profiling Tests Heightened Their Perceived Value Among Patients
BPA Stimulates Growth of Breast Cancer Cells, Diminishes Effect of Treatment
BRCA Test Results Affect Patients’ Breast Cancer Surgery Plans
Breast Cancer Diagnosis, Mammography Readings Improved by Considering Patient Risk Profile
Combo Tumor Imaging Can Distinguish Malignant and Benign Breast Tumors, Help Avoid Biopsies
Estrogen Receptor ß Limits Breast Cancer Growth and Indicates Outcome
False Negative Results Found in Prognostic Testing for Breast Cancer
Known Breast Cancer Gene Needs a Partner to Initiate and Spread Tumors
Majority of Older Breast Cancer Patients Use Hormone Treatment
New Test Predicts the Risk of Non-Hereditary Breast Cancer
New Tumor-Targeting Agent Images and Treats Wide Variety of Cancers
Periodic Drug Bursts May Enhance Chemotherapy Treatment
Possible New Weapon Found for Fighting Some Types of Breast Cancer
Potential Cholesterol Lowering Drug Has Breast Cancer Fighting Capabilities
Racial Disparities in Sentinel Lymph Node Biopsy in Women with Breast Cancer
Tamoxifen-Resistant Breast Cancer Reversed When Drug Paired with Anti-Malaria Agent
Telephone Call is Effective Support When Breast Cancer Treatment Includes Weight Loss
Tugging on the 'Malignant' Switch
Virus Kills Triple Negative Breast Cancer Cells, Tumor Cells in Mice


3D Breast Imaging Could Revolutionize Cancer Screening

In community-based radiology practice, mammography screening with 3D digital breast tomosynthesis (DBT) yielded lower recall rates, an increased overall cancer detection rate, and an increased detection rate for invasive cancer compared with 2D digital mammography (DM).

In the largest report to date, researchers at Washington Radiology Associates, PC, with offices in Washington, DC; Virginia; and Maryland, conducted a study of more than 59,000 patients. The results were striking: an increase in the detection rate for cancer overall of 28.6% and a 43.8% increase in detecting invasive cancers in patients screened with 3D DBT versus 2D DM.

"We observed a significant increase in the detection rate for cancer overall and an even greater increase in the detection rate for invasive cancer," said Julianne Greenberg, corresponding author of the study. "Our results may be a bellwether for the impact of tomosynthesis on population-based breast cancer screening."

The study was published in the American Journal of Roentgenology.

SOURCES:

American Journal of Roentgenology, online edition, June 11, 2014
American Roentgen Ray Society (http://www.arrs.org)

 
Visit the Ezine


Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon